Form 4 for NMRA Neumora Therapeutics, Inc.
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-13 · accession 0001610717-24-000338 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-13 | NMRA | Ho Maykin | Dir | A - Grant | $0.00 | +20.1K | 20.1K | New | $0 |
| D | 2024-06-14 | 2024-06-13 | NMRA | Ho Maykin | Dir | A - Grant | $0.00 | +28.6K | 28.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-13 | A | A | 20,100 | $0.00 | 20,100 | D | — | — | (F1) Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-13 | A | A | 28,571 | $0.00 | 28,571 | D | $9.95 · — to 2034-06-12 | 28,571 Common Stock | (F2) 100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024. |